You are here

Improved Rapid Detection of Biable Waterborne Pathogens

Award Information
Agency: Environmental Protection Agency
Branch: N/A
Contract: EP-D-06-014
Agency Tracking Number: EP-D-06-034
Amount: $69,983.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Solicitation Year: N/A
Award Year: 2006
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
335 Lang Blvd, Grand Isle, NY, 14072
DUNS: 001658470
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Richard Montagna
 (716) 773-4232
Business Contact
 Richard Montagna
Title: President
Phone: (716) 773-4232
Research Institution
We have previously reported a simple method to detect viable Cryptosporidium parvum oocysts in drinking water using the isothermic Nucleic Acid Sequence Based Amplification (NASBA) method, coupled with a rapid liposme nanovesicle (Nanozome)-based biosensor technology. This assay system is based upon the ability to immunocapture low numbers (i.e., five or more) oocysts and heat shock them to induce the production of a specific nRNA, which in turn, can be amplified by NASBA. Then, the resulting single stranded amplicons can be directly quantified by a rapid and visually detectable hybridization reaction employing a highly sensitive Nanozome-amplified lateral-flow assay. The entire assay, completed within 4-5 hours, can overcome many of the problems inherent in the current EPA Methods 1622 and 1623, particularly labor-intensity, inability to distinguish nonviable from viable oocysts, and deceasing the possibility of false positive determinations caused by misreading of immunofluorescence slides. While date are already available and through analyses have been carried out previously, a number of additional data points with sufficient statistical relevance are required in order to consider the NASBA/Nanozome method for possible routine use in drinking water monitoring. These analyses include confirmation that: · The designed primer pairs and probes are specific for Cryptosporidium parvum and not prone to false positive reactions against other Cryptosporidium species that do not infect humans or other microbial agents anticipated in water. · The designed primer pairs and probes can also detect C. hominis. · The test system is capable of detecting low numbers of C parvum oocysts when they are present among a large background of other microbial agents. · The entire test system can differentiate between viable and UV-irradiated oocysts. · The entire test system will yield performance specifications (i.e., sensitivity and specificity) at least a good as EPA Methods 1622 and 1623. A team of scientists at Cornell University, Innovative Biotechnologies International and Clancy Environmental Consultants, who have previously worked together on the development of the C. parvum test, will be assembled to perform the proposed work. Successful completion of the Phase I proposal will permit us to propose a Phase II effort to perform more extensive performance-based evaluation of the test protocol at a large number of water treatment utilities with the goal to achieve EPA approval a new method for routine monitoring of drinking water.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government